Skip to main content
Clinical Trials/NCT04473508
NCT04473508
Completed
Phase 3

Erectus Nerve Block for Lumbar Spine Surgery : a Prospective Randomized Study

Centre Hospitalier Universitaire de Nīmes1 site in 1 country50 target enrollmentNovember 27, 2019

Overview

Phase
Phase 3
Intervention
Local administration of ropivacaine
Conditions
Spine Surgery
Sponsor
Centre Hospitalier Universitaire de Nīmes
Enrollment
50
Locations
1
Primary Endpoint
morphine consumption (mg)
Status
Completed
Last Updated
4 months ago

Overview

Brief Summary

: Spine surgery induced severe postoperative pain. Several techniques as intravenous multimodal analgesia have been proposed to reduce pain relief and morphine rescue over the first postoperative days. Regional anesthesia using the erectus nerve block is a simple infiltration across lamina of the vertebra: Ultrasound-guided posterior ramus of spinal nerve block for anesthesia and analgesia in lumbar spinal surgery This study compared erector nerve block with local anesthetic vs placebo to reduce pain and morphine rescue after lumbar spine surgery. The investigators hypothesized that eructor nerve block induced a large block from L1 to L5 that induced posterior nerve roots block anesthesia. This block reduced pain after surgery.

Registry
clinicaltrials.gov
Start Date
November 27, 2019
End Date
September 9, 2021
Last Updated
4 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Centre Hospitalier Universitaire de Nīmes
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • age\> 18years and \<80 years
  • lumbar spine surgery (2-4 levels)
  • posterior approach

Exclusion Criteria

  • age \< 18yrs
  • \<50 kg and \>120 kg
  • renal or hepatic severe desease
  • no French speaking
  • emergency surgery
  • local or systemic infection
  • surgical resumption of the surgical site
  • surgery involving a thoracic approach
  • allergy to local anesthetics

Arms & Interventions

Treated

active treatment (Local anaesthetic): Local administration of ropivacaine 30 mL (5mg/mL)

Intervention: Local administration of ropivacaine

Control

Local administration of Placebo ( Saline Solution)

Intervention: Local administration of placebo (saline solution)

Outcomes

Primary Outcomes

morphine consumption (mg)

Time Frame: 24 Hours after surgery

Quantity administered in the post-interventional monitoring room and in hospitalization via a self-controlled morphine pump by the patient

Secondary Outcomes

  • chronic pain: DN4 questionnaire(Questionnaire DN4 at 3 months)
  • Length of hospital stay(hospital length of stay, an average of 4 days)
  • Length of stay in the post-intervention care unit(Day 1)
  • pain at rest and at movement: Visual Analogic scale(Day 1 to Day 3, Day od hospital discharge and month 3)
  • Patient Satisfaction: visual analogic scale(Day of hospital discharge, an average of day 4)
  • Adverse events(from surgery to 3 months)
  • Patient Quality of life: EQ-5D Questionnaire(3 months)

Study Sites (1)

Loading locations...

Similar Trials